Chemsex entails the consumption of certain forms of sexualised drugs before and during sexual activities to heighten pleasure. The United Nations Office on Drugs and Crime (UNODC) has associated substances such as methamphetamine, mephedrone, and gamma hydroxybutyrate (GHB)/gamma butyrolactone (GBL) with chemsex practices. In an Asia-wide review, the prevalence of sexualised drug use among men who have sex with men (MSM) ranged from 3.6% to 91.2% (3), with varying rates of chemsex from 3.1% to 30.8%. Global literature on chemsex indicated adverse impacts, such as on physical, sexual, and mental health; on users' lives; and on risky sexual behaviour, such as condomless sex.
Related Resources
Research Brief
03-May-2023
Research Brief
03-May-2023
Related Studies
Community-Based Studies
Establishing a surveillance system on SRHR of key populations (KPs) at risk of the compromised outcome of SRHR
Principal Investigator:
Dr. Md. Sharful Islam Khan
Community-Based Studies
Psychological distress and sexual health concerns among gender and sexually diverse people: Developing a culture sensitive intervention model
Principal Investigator:
Saiba jannat
Innovation Studies
Connecting gender and sexually diverse people to the essential services through ICT-based platforms
Principal Investigator:
Dr. Md. Sharful Islam Khan
Community-Based Studies
Generating evidence and policy recommendations for safeguarding sexual and reproductive health rights (SRHR) of transgender people in selected areas of Dhaka city, Bangladesh
Principal Investigator:
Samira Dishti Irfan